Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,746 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Branched-Chain Amino Acid Metabolic Reprogramming Orchestrates Drug Resistance to EGFR Tyrosine Kinase Inhibitors.
Wang Y, Zhang J, Ren S, Sun D, Huang HY, Wang H, Jin Y, Li F, Zheng C, Yang L, Deng L, Jiang Z, Jiang T, Han X, Hou S, Guo C, Li F, Gao D, Qin J, Gao D, Chen L, Lin SH, Wong KK, Li C, Hu L, Zhou C, Ji H. Wang Y, et al. Among authors: ren s. Cell Rep. 2019 Jul 9;28(2):512-525.e6. doi: 10.1016/j.celrep.2019.06.026. Cell Rep. 2019. PMID: 31291585 Free article.
Exon 20 YVMA insertion is associated with high incidence of brain metastasis and inferior outcome of chemotherapy in advanced non-small cell lung cancer patients with HER2 kinase domain mutations.
Yang S, Wang Y, Zhao C, Li X, Liu Q, Mao S, Liu Y, Yu X, Wang W, Tian Q, Pan Y, Xiong A, Chen B, Gao G, Li W, He Y, Wu F, Chen X, Su C, Ren S, Zhou C. Yang S, et al. Among authors: ren s. Transl Lung Cancer Res. 2021 Feb;10(2):753-765. doi: 10.21037/tlcr-20-559. Transl Lung Cancer Res. 2021. PMID: 33718019 Free PMC article.
Special issue "The advance of solid tumor research in China": FGFR4 alterations predict efficacy of immune checkpoint inhibitors in nonsmall cell lung cancer.
Gao G, Cui L, Zhou F, Jiang T, Wang W, Mao S, Wu F, Jiang F, Zhang B, Bei T, Xie W, Zhang C, Zhang H, Gao C, Zhao X, Bai Y, Zhou C, Ren S. Gao G, et al. Among authors: ren s. Int J Cancer. 2023 Jan 1;152(1):79-89. doi: 10.1002/ijc.34239. Epub 2022 Sep 5. Int J Cancer. 2023. PMID: 36062503 Free article.
Outcome comparison of pyrotinib with current standard of care in the second/third line setting in advanced non-small cell lung cancer patients with HER2 mutation.
Mao S, Luo L, Yang S, Wang Y, Zhou F, Yu J, Chen B, Gao G, Li X, Zhao C, Cheng L, Liu Y, Wang W, Jia K, Shao C, Liu X, Chen X, Su C, Zhou C, Wu F, Ren S. Mao S, et al. Among authors: ren s. Chin Med J (Engl). 2023 Apr 5;136(7):848-850. doi: 10.1097/CM9.0000000000002453. Chin Med J (Engl). 2023. PMID: 36921117 Free PMC article. No abstract available.
4,746 results